# Effect of Linagliptin on Vascular Inflammation in Patients With Type 2 Diabetes Mellitus

> **NCT02077309** · PHASE3 · TERMINATED · sponsor: **RWTH Aachen University** · enrollment: 4 (actual)

## Conditions studied

- Diabetes Mellitus Type 2 (T2DM)
- Vascular Inflammation
- Plaque Morphology

## Interventions

- **DRUG:** Linagliptin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02077309
- **Lead sponsor:** RWTH Aachen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-08
- **Primary completion:** 2015-09
- **Final completion:** 2015-11
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** bad recruitment of suitable participants, just 4 patients in one year
- **Last updated:** 2017-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02077309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02077309, "Effect of Linagliptin on Vascular Inflammation in Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02077309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*